Published by Alexander Bueso on 28th September 2020
(Sharecast News) - Inovio's phase 2/3 trial of its Covid-19 vaccine candidate was put on partial hold by the US Food and Drug Administration, sending the shares crashing.
URL: http://www.digitallook.com/dl/news/story/31231406/...